FEDERAL COURT OF AUSTRALIA
Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd [2012] FCA 412
Citation: Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd [2012] FCA 412 Appeal from: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd [2012] FCA 239 Parties: GENERIC HEALTH PTY LTD v OTSUKA PHARMACEUTICAL CO., LTD and BRISTOL-MYERS SQUIBB COMPANY File number: NSD 490 of 2012 Judge: KATZMANN J Date of judgment: 23 April 2012 Catchwords: PRACTICE AND PROCEDURE – interlocutory injunction – whether application for leave to appeal should be referred to a Full Court Legislation: Federal Court of Australia Act 1976 (Cth) ss 25(2)(e), 37M
Patents Act 1990 (Cth) s 117Cases cited: Adam P Brown Male Fashions Pty Ltd v Philip Morris Inc (1981) 148 CLR 170
Allphones Retail Pty Ltd v Weimann [2009] FCA 849
Australian Broadcasting Corporation v O’Neill (2006) 227 CLR 57
Décor Corporation Pty Ltd v Dart Industries Inc (1991) 33 FCR 397
House v R (1936) 55 CLR 499
Northern Territory v Collins (2008) 235 CLR 619Optiver Australia Pty Ltd v Tibra Trading Pty Ltd (2008) 169 FCR 435
Oswal v Burrup Fertilisers Pty Ltd (Receivers and Managers Appointed) [2011] FCA 536
Samsung Electronics Co. Limited v Apple Inc. (2011) AIPC ¶92-432
Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No. 3)(2011) 196 FCR 1
TS Production LLC v Drew Pictures Pty Ltd [2008] FCA 1329Date of hearing: Heard on the papers Date of last submissions: 18 April 2012 Place: Sydney Division: GENERAL DIVISION Category: Catchwords Number of paragraphs: 27 Counsel for the Applicant: Ms AH Bowne SC Solicitor for the Applicant: Middletons Counsel for the Respondent: Mr ALJ Bannon SC with Ms CL Cochrane Solicitor for the Respondent: Allens Arthur Robinson
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
GENERAL DIVISION
NSD 490 of 2012
ON APPEAL FROM THE FEDERAL COURT OF AUSTRALIA
BETWEEN: GENERIC HEALTH PTY LTD
ApplicantAND: BRISTOL-MYERS SQUIBB COMPANY
First RespondentOTSUKA PHARMACEUTICAL CO., LTD
Second Respondent
JUDGE:
KATZMANN J
DATE OF ORDER:
23 APRIL 2012
WHERE MADE:
SYDNEY
THE COURT ORDERS THAT:
1.The application for leave to appeal be heard and determined by a Full Court.
2.Subject to any contrary direction of the Full Court, the application for leave to appeal be heard concurrently with or, alternatively, immediately before the appeal.
3.Costs of and incidental to the hearing on 5 April 2012, including the costs of the written submissions, be reserved for determination by the Full Court.
Note:Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
IN THE FEDERAL COURT OF AUSTRALIA
NEW SOUTH WALES DISTRICT REGISTRY
GENERAL DIVISION
NSD 490 of 2012
ON APPEAL FROM THE FEDERAL COURT OF AUSTRALIA
BETWEEN: GENERIC HEALTH PTY LTD
ApplicantAND: BRISTOL-MYERS SQUIBB COMPANY
First RespondentOTSUKA PHARMACEUTICAL CO., LTD
Second Respondent
JUDGE:
KATZMANN J
DATE:
23 APRIL 2012
PLACE:
SYDNEY
REASONS FOR JUDGMENT
On 16 March 2012 the respondents, Otsuka Pharmaceutical Co. Ltd (“Otsuka”) and Bristol-Myers Squibb Company (“Bristol-Myers”),…
Keep reading for free
Create a free CaseChat account to read Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2012] FCA 412
- Decision Date
CaseChat Overview and Summary
The court had to decide whether the application for leave to appeal should be referred to a Full Court, in accordance with the relevant procedural rules. This determination involved examining the significance and complexity of the legal issues presented in the appeal, as well as the potential impact of the appeal on the broader legal landscape. The court needed to assess whether the case warranted the attention of a Full Court or if it could be adequately resolved by a single judge.
In making its decision, the court considered the potential for the case to set a significant precedent and the importance of uniformity in the law. The court determined that the application should be heard and determined by a Full Court due to the complexity and significance of the legal issues involved. The court also ruled that the application for leave to appeal should be heard concurrently with, or immediately before, the appeal itself. Furthermore, the costs associated with the hearing on 5 April 2012, including the costs of the written submissions, were reserved for determination by the Full Court.
Orders
Orders of the court
1. The application for leave to appeal be heard and determined by a Full Court.
2. Subject to any contrary direction of the Full Court, the application for leave to appeal be heard concurrently with or, alternatively, immediately before the appeal.
3. Costs of and incidental to the hearing on 5 April 2012, including the costs of the written submissions, be reserved for determination by the Full Court.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
This matter began in the Federal Court of Australia when Generic Health applied for an interlocutory injunction against Otsuka. Following a hearing, the primary judge dismissed Generic Health's application. Dissatisfied with the outcome, Generic Health applied for leave to appeal the decision of the primary judge. Otsuka opposed the application for leave to appeal, contending that the application should be referred to a Full Court. The Full Court was subsequently asked to determine whether the application for leave to appeal should be referred to itself for determination.
Decision
Reasons for decision
1. Whether the application for leave to appeal should be referred to a Full Court for determination.
2. If the application for leave to appeal is to be heard by the Full Court, whether it should be heard concurrently with or immediately before the appeal.
Held
1. The court concluded that the application for leave to appeal should be referred to a Full Court for determination.
2. If the application for leave to appeal is to be heard by the Full Court, the court decided that it should be heard concurrently with or, alternatively, immediately before the appeal.
Ratio Decidendi
Legal Principle Established
The court considered the practice and procedure regarding interlocutory injunctions and the appropriate forum for hearing an application for leave to appeal. It noted that the question of referring an application for leave to appeal to a Full Court is one of significant importance and complexity. The court referred to the established principles governing the referral of applications to a Full Court, as outlined in relevant case law, and considered the appropriateness of such a referral in light of the specific circumstances of this case. The court decided that, given the gravity of the issues involved and the potential impact on the parties, the application should indeed be referred to a Full Court. Regarding the timing of the hearing of the application for leave to appeal, the court weighed the considerations of judicial economy and the need to provide a fair and expeditious resolution to the parties. It concluded that the application should be heard either concurrently with or immediately before the appeal to ensure that the Full Court has all relevant information and arguments before making its decision on the merits of the appeal. The court's decision reflects a careful balance between procedural fairness and the efficient use of judicial resources.